Table of Content

1. Preface
    1.1. Report Scope and Market Segmentation
    1.2. Research Highlights

2. Assumptions and Research Methodology
    2.1. Assumptions and Acronyms Used
    2.2. Research Methodology

3. Executive Summary

4. Market Overview
    4.1. Introduction
    4.2. Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Opportunity
    4.3. U.S. OTC Topical Antifungals Market Forecast
    4.4. U.S. OTC Topical Antifungals Market Outlook

5. Market Outlook
    5.1. Porter’s Five Force Analysis
    5.2. Pricing Analysis
    5.3. Disease Prevalence & Incidence Rate
    5.4. Overview and Application of OTC Products
    5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact

6. U.S. OTC Topical Antifungals Market Analysis and Forecasts, By Drug Class
    6.1. Introduction
    6.2. U.S. OTC Topical Antifungals Market Value Share Analysis, by Drug Class
    6.3. U.S. OTC Topical Antifungals Market Forecast, by Drug Class
        6.3.1. Azoles
            6.3.1.1. Clotrimazole
            6.3.1.2. Miconazole
            6.3.1.3. Fluconazole
            6.3.1.4. Ketokonazole
            6.3.1.5. Others
        6.3.2. Allylamine
            6.3.2.1. Terbinafine
            6.3.2.2. Butenafine
            6.3.2.3. Others
        6.3.3. Tolnaftate
        6.3.4. Undecylenic Acid
        6.3.5. Others
    6.4. U.S. OTC Topical Antifungals Market Analysis, by Drug Class
    6.5. U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Drug Class

7. U.S. OTC Topical Antifungals Market Analysis and Forecasts, By Indication
    7.1. Introduction
    7.2. U.S. OTC Topical Antifungals Market Value Share Analysis, by Indication
    7.3. U.S. OTC Topical Antifungals Market Forecast, by Indication
        7.3.1. Ringworm
        7.3.2. Jock Itch
        7.3.3. Athlete’s Foot
        7.3.4. Others
    7.4. U.S. OTC Topical Antifungals Market Analysis, by Indication
    7.5. U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Indication

8. U.S. OTC Topical Antifungals Market Analysis and Forecasts, By Dosage Form
    8.1. Introduction
    8.2. U.S. OTC Topical Antifungals Market Value Share Analysis, by Dosage Form
    8.3. U.S. OTC Topical Antifungals Market Forecast, by Dosage Form
        8.3.1. Creams
        8.3.2. Gels
        8.3.3. Ointments
        8.3.4. Others
    8.4. U.S. OTC Topical Antifungals Market Analysis, by Dosage Form
    8.5. U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Dosage Form

9. U.S. OTC Topical Antifungals Market Analysis and Forecasts, By Distribution Channel
    9.1. Introduction
    9.2. U.S. OTC Topical Antifungals Market Value Share Analysis, by Distribution Channel
    9.3. U.S. OTC Topical Antifungals Market Forecast, by Distribution Channel
        9.3.1. Hospital Pharmacies
        9.3.2. Retail Pharmacies
        9.3.3. Online Pharmacies
    9.4. U.S. OTC Topical Antifungals Market Analysis, by Distribution Channel
    9.5. U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Distribution Channel

10. Competition Landscape
    10.1. Market Player – Competition Matrix (By Tier and Size of Companies)
    10.2. Market Share Analysis, by Company (2022)
    10.3. Company Profiles
        10.3.1. Novartis AG
            10.3.1.1. Company Overview
            10.3.1.2. Product Portfolio
            10.3.1.3. SWOT Analysis
            10.3.1.4. Strategic Overview
        10.3.2. Merck KGaA
            10.3.2.1. Company Overview
            10.3.2.2. Product Portfolio
            10.3.2.3. SWOT Analysis
            10.3.2.4. Strategic Overview
        10.3.3. Dr Reddy’s Laboratories Ltd.
            10.3.3.1. Company Overview
            10.3.3.2. Product Portfolio
            10.3.3.3. SWOT Analysis
            10.3.3.4. Strategic Overview
        10.3.4. Pfizer, Inc.
            10.3.4.1. Company Overview
            10.3.4.2. Product Portfolio
            10.3.4.3. SWOT Analysis
            10.3.4.4. Strategic Overview
        10.3.5. Abbott Laboratories
            10.3.5.1. Company Overview
            10.3.5.2. Product Portfolio
            10.3.5.3. SWOT Analysis
            10.3.5.4. Strategic Overview
        10.3.6. Bayer AG
            10.3.6.1. Company Overview
            10.3.6.2. Product Portfolio
            10.3.6.3. SWOT Analysis
            10.3.6.4. Strategic Overview
        10.3.7. Sanofi
            10.3.7.1. Company Overview
            10.3.7.2. Product Portfolio
            10.3.7.3. SWOT Analysis
            10.3.7.4. Strategic Overview
        10.3.8. Crown
            10.3.8.1. Company Overview
            10.3.8.2. Product Portfolio
            10.3.8.3. SWOT Analysis
            10.3.8.4. Strategic Overview



List of Figures

List of Figures

Figure 01: U.S. OTC Topical Antifungals Market Value (US$ Bn) Forecast, 2017–2031

Figure 02: U.S. OTC Topical Antifungals Market Value Share, by Drug Class, 2022

Figure 03: U.S. OTC Topical Antifungals Market Value Share, by Indication, 2022

Figure 04: U.S. OTC Topical Antifungals Market Value Share, by Dosage Form, 2022

Figure 05: U.S. OTC Topical Antifungals Market Value Share, by Region, 2022

Figure 06: U.S. OTC Topical Antifungals Market Value Share Analysis, by Drug Class, 2022 and 2031

Figure 07: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Azole, 2017–2031

Figure 08: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Allylamine, 2017–2031

Figure 09: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Tolnaftate, 2017–2031

Figure 10: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Undecylenic Acid, 2017–2031

Figure 11: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Others, 2017–2031

Figure 12: U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Drug Class, 2023–2031

Figure 13: U.S. OTC Topical Antifungals Market Value Share Analysis, by Indication, 2022 and 2031

Figure 14: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Ringworm, 2017–2031

Figure 15: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Undecylenic Acid, 2017–2031

Figure 16: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Athlete’s Foot, 2017–2031

Figure 17: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Others, 2017–2031

Figure 18: U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Indication, 2023–2031

Figure 19: U.S. OTC Topical Antifungals Market Value Share Analysis, by Dosage Form, 2022 and 2031

Figure 20: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Creams, 2017–2031

Figure 21: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Gels, 2017–2031

Figure 22: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Ointment, 2017–2031

Figure 23: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Others, 2017–2031

Figure 24: U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Indication, 2023–2031

Figure 25: U.S. OTC Topical Antifungals Market Value Share Analysis, by Dosage Form, 2022 and 2031

Figure 26: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Hospital Pharmacies, 2017–2031

Figure 27: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Retail Pharmacies, 2017–2031

Figure 28: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Online Pharmacies, 2017–2031

Figure 29: U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 30: Global OTC Topical Antifungals Market Share, by Company, 2022

List of Tables

List of Tables

Table 01: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Drug Class, 2017–2031

Table 02: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Azole, 2017–2031

Table 03: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Allylamine, 2017–2031

Table 04: U.S. OTC Topical Antifungals Market Volume (Units in Thousand) Forecast, by Drug Class, 2017–2031

Table 05: U.S. OTC Topical Antifungals Market Volume (Units in Thousand) Forecast, by Azole, 2017–2031

Table 06: U.S. OTC Topical Antifungals Market Volume (Units in Thousand) Forecast, by Allylamine, 2017–2031

Table 07: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Indication, 2017–2031

Table 08: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Dosage Form, 2017–2031

Table 09: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031